Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.

Hesseling AC, Jaspan HB, Black GF, Nene N, Walzl G.

Int J Tuberc Lung Dis. 2015 Apr;19(4):454-62. doi: 10.5588/ijtld.14.0608.

PMID:
25860002
2.

Novel application of NIH case definitions in a paediatric tuberculosis contact investigation study.

Wiseman CA, Mandalakas AM, Kirchner HL, Gie RP, Schaaf HS, Walters E, Hesseling AC.

Int J Tuberc Lung Dis. 2015 Apr;19(4):446-53. doi: 10.5588/ijtld.14.0585.

PMID:
25860001
3.

Reply to Thysen et al.

Toukam Tchakoute C, Hesseling AC, Blakney AK, Jaspan HB.

J Infect Dis. 2015 Mar 27. pii: jiv199. [Epub ahead of print] No abstract available.

PMID:
25821228
4.

Fluoroquinolones for the treatment of tuberculosis in children.

Thee S, Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS.

Tuberculosis (Edinb). 2015 Feb 14. pii: S1472-9792(14)20678-0. doi: 10.1016/j.tube.2015.02.037. [Epub ahead of print] Review.

PMID:
25797610
5.

Optimizing the Detection of Recent Tuberculosis Infection in Children in a High Tuberculosis-HIV Burden Setting.

Mandalakas AM, Kirchner HL, Walzl G, Gie RP, Schaaf HS, Cotton MF, Grewal HM, Hesseling AC.

Am J Respir Crit Care Med. 2015 Apr 1;191(7):820-30. doi: 10.1164/rccm.201406-1165OC.

PMID:
25622087
6.

Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection.

Le Doare K, Allen L, Kampmann B, Heath PT, Taylor S, Hesseling AC, Gorringe A, Jones CE.

Vaccine. 2015 Jan 29;33(5):621-7. doi: 10.1016/j.vaccine.2014.12.025. Epub 2014 Dec 24.

7.

The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.

Jones CE, Hesseling AC, Tena-Coki NG, Scriba TJ, Chegou NN, Kidd M, Wilkinson RJ, Kampmann B.

AIDS. 2015 Jan 14;29(2):155-65. doi: 10.1097/QAD.0000000000000536.

8.

Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

Thee S, Garcia-Prats AJ, Draper HR, McIlleron HM, Wiesner L, Castel S, Schaaf HS, Hesseling AC.

Clin Infect Dis. 2015 Feb 15;60(4):549-56. doi: 10.1093/cid/ciu868. Epub 2014 Oct 30.

PMID:
25362206
9.

Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis.

Seddon JA, Garcia-Prats AJ, Kampmann B, Schaaf HS, Hesseling AC.

Pediatr Infect Dis J. 2014 Oct;33(10):1098-9. doi: 10.1097/INF.0000000000000369. No abstract available.

PMID:
25361192
10.

Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation.

Garcia-Prats AJ, Zimri K, Mramba Z, Schaaf HS, Hesseling AC.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1292-8. doi: 10.5588/ijtld.13.0872.

PMID:
25299860
11.

Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.

Tchakoute CT, Hesseling AC, Kidzeru EB, Gamieldien H, Passmore JA, Jones CE, Gray CM, Sodora DL, Jaspan HB.

J Infect Dis. 2015 Feb 1;211(3):338-46. doi: 10.1093/infdis/jiu434. Epub 2014 Aug 8.

PMID:
25108027
12.

Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study.

Franck C, Seddon JA, Hesseling AC, Schaaf HS, Skinner D, Reynolds L.

BMC Infect Dis. 2014 Aug 1;14:426. doi: 10.1186/1471-2334-14-426.

13.

Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.

Walters E, Duvenhage J, Draper HR, Hesseling AC, Van Wyk SS, Cotton MF, Rabie H.

Arch Dis Child. 2014 Nov;99(11):998-1003. doi: 10.1136/archdischild-2013-305509. Epub 2014 Jun 17.

PMID:
24938535
14.

Trends in childhood drug-resistant tuberculosis in South Africa: a window into the wider epidemic?

Schaaf HS, Hesseling AC, Rautenbach C, Seddon JA.

Int J Tuberc Lung Dis. 2014 Jul;18(7):770-3. doi: 10.5588/ijtld.13.0069.

PMID:
24902550
15.

Tuberculosis control in South Africa: successes, challenges and recommendations.

Churchyard GJ, Mametja LD, Mvusi L, Ndjeka N, Hesseling AC, Reid A, Babatunde S, Pillay Y.

S Afr Med J. 2014 Mar;104(3 Suppl 1):244-8.

PMID:
24893501
16.

Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB gold in-tube in young children evaluated for tuberculosis in Southern India.

Jenum S, Selvam S, Mahelai D, Jesuraj N, Cárdenas V, Kenneth J, Hesseling AC, Doherty TM, Vaz M, Grewal HM.

Pediatr Infect Dis J. 2014 Oct;33(10):e260-9. doi: 10.1097/INF.0000000000000399.

17.

In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.

Kidzeru EB, Hesseling AC, Passmore JA, Myer L, Gamieldien H, Tchakoute CT, Gray CM, Sodora DL, Jaspan HB.

AIDS. 2014 Jun 19;28(10):1421-30. doi: 10.1097/QAD.0000000000000292.

18.

Managing multidrug-resistant tuberculosis in children: review of recent developments.

Schaaf HS, Garcia-Prats AJ, Hesseling AC, Seddon JA.

Curr Opin Infect Dis. 2014 Jun;27(3):211-9. doi: 10.1097/QCO.0000000000000062. Review.

PMID:
24751893
19.

The BCG replacement vaccine VPM1002: from drawing board to clinical trial.

Kaufmann SH, Cotton MF, Eisele B, Gengenbacher M, Grode L, Hesseling AC, Walzl G.

Expert Rev Vaccines. 2014 May;13(5):619-30. doi: 10.1586/14760584.2014.905746. Epub 2014 Apr 7. Review.

PMID:
24702486
20.

Determinants of tuberculosis treatment completion among newborns in a high-burden setting.

Bekker A, Slogrove AL, Schaaf HS, Du Preez K, Hesseling AC.

Int J Tuberc Lung Dis. 2014 Mar;18(3):335-40. doi: 10.5588/ijtld.13.0506.

PMID:
24670572
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk